DON LUONG M.D. NPI 1992904379

NPI Information

  • NPI: 1992904379
  • Provider Name: DON LUONG, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 8787 BRYAN DAIRY RD
    SUITE 210
    LARGO, FL
    ZIP 33777
  • Phone: (727) 397-9641

Map and Directions

Get Directions

NPI Details

Don Luong, M.D. is a medical oncology internal medicine in Largo, FL with 24 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Don Luong, M.D. NPI is 1992904379. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

8787 BRYAN DAIRY RD
SUITE 210
LARGO, FL
ZIP 33777-251
Phone: (727) 397-9641
Fax: (727) 393-4194

The NPI 1992904379 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Blood test, clotting time (HCPCS:85610)
  • Magnesium level (HCPCS:83735)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Folic acid level, serum (HCPCS:82746)
  • Protein measurement, serum (HCPCS:84165)
  • Red blood count, automated test (HCPCS:85045)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Red blood count, manual test (HCPCS:85044)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Automated urinalysis test (HCPCS:81003)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Red blood count automated, with additional calculations (HCPCS:85046)

The enumeration date for this NPI number is 7/16/2007 and was last updated on 8/10/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyME92986FLORIDANo
2207RX0202XInternal MedicineMedical OncologyME92986FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1281188000MEDICAIDFLORIDA
262601OTHERBLUE CROSS / BLUE SHIELD
3P000615853OTHERFLORIDAMEDICAID RR

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.